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Rosai-Dorfman Disease or Sinus Histiocytosis with Massive 
Lymphadenopathy (SHML) is a rare benign disease of unknown 
etiology, which presents with cervical lymphadenopathy. It 
is usually seen in younger patients. The extranodal form 
affect various regions of the head and neck, and is more 
common in patients with immune abnormalities. It is a self-
limited and seldom life-threatening disease, rendering therapy 
unnecessary in most cases. For those who require therapy 
because of persistent or worsening symptoms, treatments 
modalities include surgery, chemotherapy, radiotherapy and 
steroids. The authors describe one case of a 43-year-old man 
with bilateral cervical masses, nasal obstruction, fever, weight 
loss and decreased vision with 6 months duration. As his 
social history was positive for tobacco and alcohol use, the 
initial diagnosis was a possible rhinopharyngeal malignant 
tumor. Medical investigation established the diagnosis of 
SHML. After therapy, the 6-month follow-up evidenced the 
patient´s clinical improvement, although cervical masses 
persisted. The clinical presentation, histological features, 
pathogenesis and treatment of this case are discussed.
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INTRODUCTION
Sinus histiocytosis with massive lymphadenopathy 
(SHML) was described in 1969 by Rosai and Dorfman in 
a report of four cases;1 the same authors characterized 
this disease in greater detail in 1972.2 It is a rare, benign 
lymphoproliferative condition presenting with painless 
cervical lymphadenopathy, fever, leukocytosis with 
neutrophilia, increased hemosedimentation rate and 
polyclonal hypergammaglobulinemia.3,4 Other lymph 
node groups may be involved; 30-40% of cases have 
extranodal disease.1-3,6 This condition generally affects 
children and young adults;5 the mean age at presentation 
is 19.7 years.4 It affects equally white and black people, 
and is less frequent in Asians. The disease is found worl-
dwide and appears to affect males more than females, in 
a 1.4:1.0 ratio.6 Its etiology remains uncertain. Possible 
causes include altered immune responses and infections 
by agents such as varicella-zooster and other herpetic 
viruses, Epstein-Barr and cytomegalovirus, Brucella and 
Klebisiela.4 Treatment is controversial. Other modalities 
have been attempted, such as surgery, antibiotics, radio-
therapy, chemotherapy and steroids, sometime in combi-
nation; none has provided consistent results. We present 
a case that was diagnosed and treated in our clinical unit, 
and make a brief review of the literature.
CASE REPORT
GCO, a male patient aged 43 years, sought the 
otorhinolaryngology and head & neck surgery unit pre-
senting bilateral neck masses, nasal block, significant 
weight loss, malaise, evening fever and loss of vision. 
These symptoms had progressed during the past 6 
months. There was no nasal bleeding, odynophagia or 
dysphonia.
The physical examination showed bilateral neck 
nodules of different sizes, as shown in figure 2. The 
nodules were coalescent, adhered to deeper planes and 
painless. There were no other findings.
Fine needle aspiration biopsy (FNAB) was done of 
a nodule. Other exams were nasal endoscopy, computed 
tomography (CT) of the neck, a complete blood count, 
hepatic function tests, screening for autoimmune diseases, 
VDRL and HIV serology, and testing for toxoplasmosis. 
These exams revealed leukocytosis and neutrophilia. Anti-
HIV, VDRL and serology for toxoplasmosis were negative. 
The FNAB was non-conclusive; there were lymphocytes, 
occasional neutrophils and no neoplastic cells.
Nasal endoscopy showed a large lobulated tumor 
in the cavum (Figure 1), which occluded most of the cho-
anae. CT of the neck showed an expanding solid lesion in 
the retropharyngeal and parapharyngeal space, projecting 
into the nasopharyngeal lumen. There was also cervical 
and submandibular lymph node enlargement.
The tumor was biopsied under endoscopic view. 
Histology showed a diffuse submucosal infiltration by 
plasma cells containing lymphocytes within their cyto-
plasm.
While these exams were done, the patient wor-
sened progressively, presenting bilateral axillary and 
inguinal lymph node enlargement, diffuse facial skin 
lesions and further loss of vision.
Histological findings suggested extranodal Rosai-
Dorfman disease.
Corticosteroid therapy was initiated (prednisone 
1mg/kg/day) and adequate clinical control.
The 6-month follow-up showed that the patient 
improved significantly, but the neck masses regressed 
only slightly.
Figure 1. Endoscopic image of a tumor in the cavum.
Figure 2. Cervical lymph node enlargement.
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DISCUSSION
SHML is a rare cause of lymph node enlargement 
in children and young adults; 80% of cases occur under 
the age 20 years. Many cases of extranodal involvement 
have been described since 1969. Apparently, there is no 
relation between lymph node and extranodal disease; 
they may even occur separately.2
The etiology is uncertain, although agents such as 
the Epstein-Barr or herpes viruses are important in the 
pathogenesis.3
The onset of SHML is typically insidiously; the 
active phase is prolonged, there may be spontaneous 
remission and subsequent relapses.3 Factors that deter-
mine recurrences and is frequency are not well unders-
tood. Deaths have been reported due to infiltration of 
vital organs, such as the liver.4 The neck lymph nodes 
are the most frequently involved, followed by inguinal, 
axillary and mediastinal lymph nodes.5 The most common 
extranodal sites are the skin, the upper respiratory tract 
and bones. Head and neck involvement - about 22% of 
extranodal disease4,5 - include involvement of the nasal 
cavity, the paranasal sinuses, the nasopharynx, subman-
dibular glands, the parotid, the larynx, the temporal bone, 
the intratemporal fossa, the pterygoid fossa, the meninges 
and the orbit.5 The skin is commonly affected; half of 
these patients have another associated extranodal site. 
Orbit and ocular glove involvement have been reported, 
usually as a retroorbitary mass and proptosis.6
The differential diagnosis of extranodal SHML 
may be a challenge, and is based on the clinical and 
histological examination. Histology shows typical featu-
res, such as diffuse lymphoplasmatic infiltration, Russel 
bodies, foamy histiocytes and histiocytes with phagocyto-
sed lymphocytes within the cytoplasm (emperipolesis). 
Immunohistochemical features include positive S-100, 
alpha-antichymotrypsin and CD1a and CD68 antigens.4,5 
Imaging (CT and magnetic resonance imaging) may be 
used to assess disease extension. If there is cervical lymph 
node enlargement, FNAB or lymph node biopsies may 
be useful for the diagnosis.3
In the case above, FNAB and a cervical biopsy 
were done to exclude the possibility of neck metastases 
from local malignancies. Nasal endoscopy was extremely 
useful in detecting the primary lesion, and CT of the neck 
demonstrated the disease extension.
The differential diagnosis is made with lymphore-
ticular malignancies such as lymphomas, Hodgkin’s dise-
ase, malignant histiocytosis and monocytic leukemia, all 
of which have similar histopathological features. Atypias 
in cytology and the aggressive clinical course establish 
the diagnosis in most cases. Other histiocytoses, such as 
rhinoscleromas, Wegener’s granulomatosis, may also be 
included in the differential diagnosis.6 Serology for HIV, 
toxoplasmosis and syphilis was done since these condi-
tions are not rare in our context. Extranodal manifesta-
tions in the head and neck are significantly more common 
in SHML patients with immunological abnormalities.4,5 
SHML has been described in HIV-infected patients. An 
altered immune system and liver, kidney or lower airway 
involvement are considered as factors that worsen the 
prognosis.3
Immunohistochemical exams were not done in 
our patient; the public health system (Sistema Unico 
de Saude) did not authorize these tests. The diagnosis, 
therefore, was confirmed histologically.
The patient next underwent radiological and 
other image diagnostic tests (a chest X-ray, abdominal 
ultrasound and CT of the head) to investigate further 
extranodal involvement. The rhinopharyngeal lesion and 
diffuse skin lesions on the face were considered extra-
nodal involvement of this disease. We did not correlate 
poor vision with the disease in this patient.
There is no ideal protocol for the treatment of 
SHML; it is an uncommon, self-limited disease that fre-
quently requires no therapy. Treatment is only necessary 
when lymph node or extranodal tissue enlargement 
causes significant symptoms, such as airway obstruction 
or compression of vital organs. Pulsone at al. reviewed 
80 cases published between 1969 and 2000; 50% of the-
se cases required no treatment, of which 82% had full 
remission.4 The role of surgery is mostly for biopsies 
and to relieve obstruction.3 Local recurrence is frequent 
following surgical resection. The role of radiotherapy is 
not well understood; some reports have described full 
resolution with this treatment, while others have shown 
no response.2 Steroids often resolve fever and reduce 
lymph node size. Chemotherapy has yielded contro-
versial results. A possible efficacy of methotrexate and 
6-mercaptopurine requires further investigation. Other 
reports have suggested using alpha-interferon, although 
its side effects have limited its use.4
We treated our patient with corticosteroids, to 
which he responded well. The patient was sent to an 
oncology unit for chemotherapy, which was eventually 
not done. Surgery was not required, given the benign 
nature of the condition.
FINAL COMMENTS
SHML is rare, requiring knowledge of its main clini-
cal manifestations for a correct diagnosis. The differential 
diagnosis includes a variety of diseases. The diagnosis of 
SHML is made by histopathology; other exams may be 
useful. Therapy and when to begin treatment remains 
controversial. Follow-up is necessary to avoid relapses.
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